EMMALEE COLBY: Open Payments
NPI 1326565524 · MALONE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 34 payments from 14 companies in 2025. Trend: 2023 $790 · 2024 $465 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $228 |
| Novo Nordisk Inc | 5 | $102 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Viatris Specialty LLC | 2 | $54 |
| Amgen Inc. | 3 | $50 |
| Lilly USA, LLC | 2 | $42 |
| Astellas Pharma US Inc | 1 | $36 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $25 |
Products named: UBRELVY, QULIPTA, Ozempic, YUPELRI, MOUNJARO, REXULTI, AIRSUPRA, Wegovy.
Industry payments across NY — which companies pay providers there.
